Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UpSwinG: Real World Study on TKI Activity in Uncommon Mutations and Sequencing Giotrif®

NCT04179890 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT04179890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04179890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UpSwinG: Real World Study on TKI Activity in Uncommon Mutations and Sequencing Giotrif®
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
December 17, 2019
Completion date
July 22, 2021
Enrollment
462 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous, non-small cell lung cancer